2023
DOI: 10.1021/acs.jafc.3c01262
|View full text |Cite
|
Sign up to set email alerts
|

Ginsenoside F4 Alleviates Skeletal Muscle Insulin Resistance by Regulating PTP1B in Type II Diabetes Mellitus

Yujie Zhao,
Yao Liu,
Jianjun Deng
et al.
Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 9 publications
(2 citation statements)
references
References 39 publications
0
2
0
Order By: Relevance
“…The inhibition of this enzyme by GF4 resulted in increased insulin receptor and insulin receptor substrate 1 tyrosine phosphorylation and enhanced insulin sensitivity. Overall, GF4 activates the insulin signaling pathway by inhibiting PTP1B [41]. Further, GF4 has an inhibitory effect on human lymphocytoma Jurkat (JK) cell by inducing apoptosis [42].…”
Section: Ginsenoside F4 (Gf4)mentioning
confidence: 99%
“…The inhibition of this enzyme by GF4 resulted in increased insulin receptor and insulin receptor substrate 1 tyrosine phosphorylation and enhanced insulin sensitivity. Overall, GF4 activates the insulin signaling pathway by inhibiting PTP1B [41]. Further, GF4 has an inhibitory effect on human lymphocytoma Jurkat (JK) cell by inducing apoptosis [42].…”
Section: Ginsenoside F4 (Gf4)mentioning
confidence: 99%
“…CHM may improve serum glucose regulation ( Yang et al, 2023 ). For example, ginseng was shown to positively impact glucose metabolism, reduce insulin resistance, and increase energy expenditure ( Zhao et al, 2023 ).Cinnamon was found to have anti-inflammatory effects and the ability to lower fasting blood sugar levels ( Liu et al, 2023a ). A CHM formula is made of multiple botanical drugs with specific properties that, when combined, may enhance the overall therapeutic effects ( Lee et al, 2022 ).…”
Section: Introductionmentioning
confidence: 99%